Hospira quarterly earnings down on Mayne expenses
CHICAGO, Aug 8 (Reuters) - Hospira Inc. (HSP.N), a maker of hospital products and specialty pharmaceuticals, on Wednesday said its quarterly net earnings fell on costs from its acquisition of Mayne Pharma.
Second-quarter net earnings dropped to $30.7 million, or 20 cents per diluted share, from $54.2 million, or 34 cents per share, a year earlier.
Excluding special items, the Lake Forest, Illinois-based company said it had earned 49 cents per share.
Wall Street analysts on average had forecast profit of 48 cents a share excluding one-time items, according to Reuters Estimates.
Quarterly sales jumped nearly 30 percent to $869.4 million, fueled by Mayne results. Excluding Mayne, sales grew just 2.8 percent. (Reporting by Debra Sherman)










